Strangles Vaccine

Dechra Strangvac vaccine is indicated for horses at high risk of exposure to the bacterium Streptococcus equi.

High-Risk Environments: Livery yards, equestrian centers, studs, and premises receiving many new horses.
Frequent Travel: Horses attending shows, clinics, or group rides.
Young Horses: Weanlings and yearlings are particularly susceptible.
Poor Biosecurity: Yards with suboptimal management or frequent interaction with outside horses.
Controlling Outbreaks: To reduce infection severity and shedding, minimizing yard-wide risk.

What is does

Protects against strangles: Protects against infection from Streptococcus equi, a common cause of strangles in horses.
Reduces clinical signs: Lowers the severity of symptoms, including high temperature, coughing, and difficulty swallowing.
Decreases abscesses: Helps reduce the formation of lymph node abscesses.
Minimizes disease spread: Vaccinated horses shed fewer bacteria, reducing the risk of transmitting the disease to other horses.
Has DIVA capability: The vaccine is designed to differentiate between vaccinated and infected animals (DIVA) on diagnostic tests.

Shake Well: Always shake the vial thoroughly before use.
Injection Site: Administer intramuscularly (IM), typically in the neck or hindquarters.
Dose: One 2 ml dose.

Vaccination Schedule:

Primary Course: Two doses, 4 weeks apart, starting from 5 months of age.
Booster: Every 6-12 months, especially for high-risk horses where a booster might be needed after 2 months.
Restarting: If a booster is missed by more than one month, the primary course may need to be repeated.

Reviews

There are no reviews yet.

Be the first to review “Strangles Vaccine”